Last reviewed · How we verify
Randomize
At a glance
| Generic name | Randomize |
|---|---|
| Also known as | Triple therapy |
| Sponsor | Hospitales Universitarios Virgen del Rocío |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Teletherapy in Children Who Are Deaf and Hard of Hearing (NA)
- Allograft vs. Autograft Nonunion (NA)
- A Single-Blind Randomized Controlled Study Comparing the Efficacy of High-Intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis (NA)
- A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis (PHASE3)
- Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer (PHASE2)
- I Kua na'u Advance Care Planning for Native Hawaiian Elders (NA)
- SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates (PHASE2)
- Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Randomize CI brief — competitive landscape report
- Randomize updates RSS · CI watch RSS
- Hospitales Universitarios Virgen del Rocío portfolio CI